Isogenica
Isogenica are experts in VHHs - highly versatile small format antibodies which we use to construct next generation biotherapeutics for the treatment of cancer, inflammation and other serious diseases.
VHHs can be assembled to create bi- and multi-specific biotherapeutics, or used to achieve targeted drug delivery as components of ADCs and cell and gene therapies including CAR-Ts.
Isogenica’s bespoke partnerships with global biopharmaceutical companies have resulted in a deep pipeline including two Clinical Phase assets and partnered pre-clinical and discovery programs.We are also seeking to out-license in-vivo validated pre-clinical stage VHH assets, including half-life extension modules.
Dr David Mead
Director Business Development
Research Donors
Research Donors collects, processes and delivers human blood biospecimens that meet the most demanding research requirements. With a diverse community of over 2500 donors, we can meet any donor specification as required by your project. Fresh HLA typed human leukopaks, PBMCs, whole blood and blood derivatives, all consented for commercial and genetic research, can be delivered within 24 hours of collection across Europe.
Research Donors only provides samples that have been collected under the most stringent levels of ethics and consent. All our samples are:Collected from donors with full genetic & commercial research consent
Collected & processed in a UK ISO accredited facility
Samples anonymised but traceable to origin Research Donors is:
A Human Tissue Authority (HTA) licensed establishment: License Number 12693
A Health Research Authority (HRA) ethically approved research tissue bank
Dr Vashu Pamnani
Senior Business manager
Sekisui
BioProduction by Sekisui offers contract development and manufacturing for the biopharmaceutical industry.
Our facility in the UK has over 40 years of microbial fermentation and purification experience and are in the midst of a $19M GMP expansion to expand drug substance manufacturing. We offer expertise in bioprocess development, scale up and manufacturing of enzymes, plasmids, chromatography ligands and other proteins for use in biopharmaceuticals.
Our facility in the UK has over 40 years of microbial fermentation and purification experience and are in the midst of a $19M GMP expansion to expand drug substance manufacturing. We offer expertise in bioprocess development, scale up and manufacturing of enzymes, plasmids, chromatography ligands and other proteins for use in biopharmaceuticals.
Jim Alferman
Associate Director, Business Development
